Scientists continue to break new ground in the realm of cellular reprogramming, a burgeoning area of medical research where one type of cell is retrained to fulfill the role of another. A team at Ohio ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a ...
Correspondence to Dr Iain Mayank Dutia, The University of Queensland School of Human Movement and Nutrition Sciences, Saint Lucia, QLD 4072, Australia; i.dutia{at}uq.edu.au Objective This study aims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results